Skin-like, stretchable, and wearable sensors for monitoring QT interval and hemodynamic variables in Atrial Fibrillation
用于监测房颤 QT 间期和血流动力学变量的类肤、可拉伸和可穿戴传感器
基本信息
- 批准号:10580853
- 负责人:
- 金额:$ 4.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-01 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AccelerometerAdherenceAdultAffectAgeAmbulatory CareAmbulatory MonitoringAmerican Heart AssociationAmiodaroneAnti-Arrhythmia AgentsArrhythmiaAtrial FibrillationAzithromycinBiomechanicsBloodBlood PressureBlood flowBody SurfaceBrainCOVID-19 pandemicCardiacCardiac MyocytesCardiac OutputCardiac ablationCaringChestChest PainClinicalComplexCongestive Heart FailureContractsCritical CareDangerousnessDataDementiaDetectionDiagnosisDiseaseDoseEFRACEKG P WaveEKG QRS ComplexElderlyElectric CountershockElectrocardiogramEventFundingFutureHealth Care CostsHealthcare SystemsHeartHeart AtriumHolter ElectrocardiographyHospitalizationHospitalsHourHydroxychloroquineIndividualInpatientsInterventionIon ChannelLeadLeft atrial structureLifeLightLightheadednessLimb structureLocationMachine LearningMeasurementMeasuresMedicalMembrane PotentialsMethodsMonitorMorbidity - disease rateOperative Surgical ProceduresOrganOutpatientsPatientsPerfusionPharmaceutical PreparationsPharmacological TreatmentPhotoplethysmographyPhysiologic MonitoringPhysiologicalPopulationPotassiumPotassium Channel BlockersRecommendationReportingResearchRestRiskRisk ReductionShortness of BreathSignal TransductionSkinSotalolStreamStroke VolumeSurfaceSymptomsSyncopeSystemSystolic Time IntervalsTachyarrhythmiasTechniquesTechnologyTherapeuticTherapeutic EmbolizationThrombotic StrokeThrombusTimeTorsades de PointesUniversitiesVentricularaging populationbioelectricityclinical carecohortcomorbiditycostdata streamsdofetilidedronedaroneflexibilityheart electrical activityheart functionheart rate monitorheart rate variabilityheart rhythmhemodynamicshigh riskhuman old age (65+)incremental costinterestlifetime riskmonitoring devicenon-invasive monitorpersonalized medicinepharmacologicpreventresearch clinical testingrestorationsensorsexside effectstandard of carestroke risktelemonitoringtreatment responsewearable devicewearable sensor technologywireless
项目摘要
Project Summary
Atrial Fibrillation (AF) is the most common sustained arrhythmia in adults, carries a lifetime risk of 25-33%,
and cost the US healthcare system > 6 Billion dollars a year. Morbidities from AF include congestive heart failure,
dementia, symptoms due to decreased cardiac output, and most importantly an elevated thrombotic stroke risk
due to blood stasis. Recent advances in wearable technology have increased the capacity and accuracy of AF
diagnosis through monitoring heart rate variability in an ambulatory setting. However, there remains no
available ambulatory technologies that permit continuous assessment of the hemodynamic effects of
AF nor measurements of cardiac repolarization that determine the proarrhythmic effects of
antiarrhythmic drugs. Some treatment aspects of AF have remained controversial due to limited efficacy of
rhythm control interventions including cardiac ablation and pharmacologic therapy, both of which have significant
risks. Pharmacologic interventions using Class III antiarrhythmics are especially risky due to the proarrhythmic
effects on ventricular repolarization which can lead to life-threatening ventricular tachyarrhythmias such as
torsades de pointes. As a result of these issues, careful assessment of ventricular repolarization, as represented
by the QT interval on the electrocardiogram (ECG), is required during drug initiation. This requires lengthy and
costly inpatient monitoring during drug loading and difficulties in maintaining the narrow therapeutic window after
discharge. Having a reliable method to quantify measures of hemodynamic instability that leads to some AF-
related symptoms, as well as continuously monitoring the QT interval and other clinically important parameters
in an ambulatory setting would allow clinicians to tailor their care to the individual. This proposal aims to refine
a flexible, non-obtrusive wearable system to continuously monitor these key clinical parameters, help in
predicting heart rhythm complications and regulate medication intervention for both rhythm control and
rate control of AF. A sensor suite consisting of a small, wireless and flexible chest-worn patch that measures
both ECG and accelerometer based seismocardiography (SCG) and a wirelessly time synchronized flexible limb
unit capable of monitoring photoplethysmographic (PPG) signals will be used. Aim 1 will quantitatively define the
optimal location for QT interval monitoring on the surface of the chest. Aim 2 will combine the ECG, SCG, and
PPG data streams and extract both unique and time-relational parameters from the signal streams known to be
related to cardiac function and hemodynamics, using machine learning to obtain predictions of hemodynamic
instability from these complex relationships. Aim 3 will address the use and compliance of this wearable system
in a clinical setting against the standard of care during Class III antiarrhythmic drug loading and pharmacologic
cardioversion. The results from this study will provide the first ambulatory measures of AF symptoms and
responses to treatment, informing future studies and clinical care teams of the dominant bioelectrical and
biomechanical parameters that are the most important in the care of the growing, aging population with AF.
项目摘要
心房颤动(AF)是成人中最常见的持续性心律失常,终生风险为25- 33%,
每年花费美国医疗系统超过60亿美元。AF的发病率包括充血性心力衰竭,
痴呆,心输出量减少引起的症状,最重要的是血栓性卒中风险升高
由于血液淤滞。可穿戴技术的最新进展提高了AF的容量和准确性
通过在门诊环境中监测心率变异性进行诊断。然而,仍然没有
现有的流动技术,允许连续评估血液动力学影响的
AF也不测量心脏复极,以确定预防作用
抗抑郁药AF的一些治疗方面仍然存在争议,因为
心律控制干预,包括心脏消融和药物治疗,两者都有显着的
风险由于致心律失常,使用III类抗心律失常药物的药物干预尤其危险
对心室复极的影响,可导致危及生命的室性快速性心律失常,
尖端扭转型室性心动过速由于这些问题,仔细评估心室复极,如所代表的
通过心电图(ECG)上的QT间期,在药物启动期间需要。这需要很长的时间,
在药物负荷期间昂贵的住院监测和维持狭窄的治疗窗口的困难,
放电有一种可靠的方法来量化血液动力学不稳定的测量,导致一些AF-
相关症状,以及持续监测QT间期和其他临床重要参数
在流动环境中,将允许临床医生为个体定制他们的护理。该提案旨在完善
一个灵活的、非侵入性的可穿戴系统,可持续监测这些关键临床参数,
预测心律并发症,并规范心律控制和
AF的速率控制。一种传感器套件,由一个小型、无线和灵活的胸戴式贴片组成,
基于ECG和加速度计的心震描记术(SCG)和无线时间同步的柔性肢体
将使用能够监测光电体积描记(PPG)信号的装置。目标1将定量定义
QT间期监测的最佳位置在胸部表面。目标2将联合收割机结合ECG、SCG和
PPG数据流,并从已知的信号流中提取唯一的和时间相关的参数。
与心脏功能和血液动力学相关,使用机器学习来获得血液动力学的预测
这些复杂关系的不稳定性。Aim 3将解决这种可穿戴系统的使用和合规性问题
在III类抗肿瘤药物负荷和药理学期间,
心脏复律这项研究的结果将提供AF症状的第一个动态测量,
对治疗的反应,通知未来的研究和临床护理团队的主要生物电和
生物力学参数,这是最重要的护理不断增长,老龄化人口与AF。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andreas Tzavelis其他文献
Andreas Tzavelis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andreas Tzavelis', 18)}}的其他基金
Skin-like, stretchable, and wearable sensors for monitoring QT interval and hemodynamic variables in Atrial Fibrillation
用于监测房颤 QT 间期和血流动力学变量的类肤、可拉伸和可穿戴传感器
- 批准号:
10490960 - 财政年份:2021
- 资助金额:
$ 4.41万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 4.41万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 4.41万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 4.41万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 4.41万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 4.41万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 4.41万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 4.41万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 4.41万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 4.41万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 4.41万 - 项目类别: